HIT Consultant

HIT Consultant is a recognized digital media platform dedicated to healthcare technology. It offers compelling interviews, engaging videos, podcasts, and thorough insights that contribute to the evolving world of healthcare technology.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#882488

United States

#406260

Health/Health

#7025

Traffic sources

Monthly visitors

Articles

Lucet Acquires Value-Based Medical Group Emcara Health

4 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Lucet, a behavioral health company providing tech-enabled services to health plans, employers, and providers, today announced its acquisition of Emcara Health (previously PopHealthCare, a GuideWell Company). Financial details of the acquisition were not disclosed. – Emcara Health is a national, value-based medical group focused on delivering home-based care to clinically complex and high-risk populations.
Zelis Acquires Medxoom Assets from Allied Benefit Systems

4 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Zelis, a provider of healthcare technology solutions announced its acquisition of the assets of Medxoom, a mobile-first member experience platform, from Allied Benefit Systems, LLC, the largest independent third-party administrator (TPA) in the United States. Financial details of the acquisition were not disclosed.
Sutter Health Receives $110M Gift to Expand Care and Innovation

4 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Sutter Health today announced it has received an unprecedented $110M philanthropic gift from a long-standing anonymous donor—the largest single donation in the not-for-profit health system’s history. – The historic contribution is set to accelerate Sutter Health’s strategic expansion and innovation initiatives, reinforcing its vision to deliver high-quality, comprehensive, and accessible care to communities across Northern California.
Swedish Femtech Venture Studio Daya Ventures Raises Capital

5 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Daya Ventures, a Swedish venture studio that has rapidly established itself by building femtech companies from scratch, today announced the first close of its ongoing funding round. – The company has successfully secured SEK 2 million of a total targeted SEK 8 million, with investments from high-profile backers from both Wall Street and Europe.
Oxford Cancer Biomarkers and Mira Precision Health Partnership

5 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc. – This collaboration aims to advance OCB’s proprietary ToxNav® test in the United States, a revolutionary precision oncology tool designed to identify patients at high risk of severe toxicity from common chemotherapy treatments.
Noom Launches Free Menopause Education Hub

5 days ago | hitconsultant.net | Jasmine Pennic

What You Should Know: – Noom, a digital healthcare company focused on chronic disease prevention launches its new Menopause Education Hub. This free resource aims to help women navigate the complexities of menopause with tools and support developed in partnership with NYT bestselling author, podcaster, filmmaker, and menopause advocate Tamsen Fadal. – As part of this collaboration, Tamsen Fadal joins Noom as the brand’s first-ever Official Menopause Awareness Advocate.
Helix Launches New PGx Tests for Chemotherapy (DPYD) & Alzheimer's Drug (APOE) Safety

1 week ago | hitconsultant.net | Fred Pennic

What You Should Know: – Helix, a leader in precision health announced the release of a new suite of pharmacogenomics (PGx) tests designed to enhance personalized care, particularly in oncology and neurology. – Key among these are a test to identify patients with DPYD gene variants who may be at increased risk for severe side effects from certain chemotherapies, and a first-of-its-kind test that assesses APOE status relevant to newly available Alzheimer’s drugs.
Abridge Launches AI-Powered Pediatric Well Visit Note Type

1 week ago | hitconsultant.net | Fred Pennic

What You Should Know: – Abridge, a company specializing in AI-powered clinical documentation, announced the launch of a new pediatric well visit note type within its platform. – The enhancement leverages Abridge’s advanced Contextual Reasoning Engine to automatically generate clinically useful and billable documentation tailored to the unique, structured needs of pediatric well visits, which vary significantly by a child’s age and developmental stage.
Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering

1 week ago | hitconsultant.net | Fred Pennic

What You Should Know: – Biotechnology company kyron.bio announced the successful closing of a $6.2M (€5.5M) seed funding round aimed at solving critical challenges in biologic drug development, specifically varying efficacy and the dangers of side effects. – The round was led by HCVC, with participation from Verve Ventures, Entrepreneurs First, Saras Capital, and numerous reputable angel investors.
NationsBenefits, Walmart to Transform Health Plan Member Access

1 week ago | hitconsultant.net | Fred Pennic

What You Should Know: – NationsBenefits®, a healthcare fintech, supplemental benefits, and outcomes platform, and Walmart, the world’s largest retailer announced they are continuing to work together to revolutionize how health plan members access essential benefits through innovative, tech-powered tools.